Moreover, HMGB1 levels are predictive of time-to-first acute pulmonary exacerbation (APE), number of future APEs within 5 years and time-to-lung transplantation or death in CF patients (Liou et al. 2012). This evidence concerns the gene HMGB1 and cystic fibrosis.